http://www.doh.gov.ph/
Philippines Registered Drug database and drug price indicator both are integrated in a single well managed database by Department of Health of Republic of the Philippines.
Registered database provides the real time information and can be found on website search results with appropriate keywords. Database provides the following search results like:
1. Acquisition Cost
2. Quantity
3. Brand Name
4. Manufacturer
5. Supplier
Drug search pattern is equivalent to the BNF of UK i.e. Drug Search by BNF Therapeutic Categories.
Pricing:
A good transparency has been maintained by the MoH, Philippines. The following type of Drug prices has been give on website
Drug Price Watch For Consumer
Drug Price Reference for Government
2015 Drug Price Reference Index Booklet
Drug Price Reference Index (DPRI) for all essential medicines to guide is published annually. Latest version in pdf format is valuable for the year 2016.
Also old edition of the same are available on the website like;
DPRI Booklet
a. Drug Price Reference 2016
b. Drug Price Reference 2015
c. Drug Price Reference 2013
d. Drug Price Reference 2012
What is the Drug Price Reference Index (DPRI)? The DPRI lists the ceiling prices of essential medicines for government bidding and procurement set by the DOH for all National and Local Government Health Facilities and Government Agencies. Winning bid prices of essential medicines within the DPRI ceiling reflect efficient and effective procurement in the government. Their transparencies and enforcement ensure consumer access to medicines and protection from excessive price mark-ups on medicines. The DPRI only reflects the acquisition costs including landed cost, packaging, drug content, quality assurance, manufacturing overheads and Food and Drug Administration (FDA) fees. The DPRI excludes other costs such as pharmacy services, preparation and storage fees, and other reasonable pharmacy mark-ups, which are now being evaluated by the DOH. The DPRI aims to improve the efficiency and good governance in the pricing and procurement of medicines in the public sector through establishing a transparent and publicly available reference price for affordable and quality medicines. It also aims to guide the Philippine Health Insurance Corporation (PHIC) in setting reimbursement caps for medicines both for inpatient and outpatient services. Who should use the DPRI? All government entities should be guided by the DPRI when procuring medicines. It shall be applied to all forms of procurement such as public bidding, direct contracting, shopping, negotiated procurement, emergency procurement and consignment to ensure that the government achieves the best value for money in sourcing essential medicines.
Disclaimer: All prices reflected are based on the lowest bidding procurement price conducted last 2015 of all DOH Hospitals. All manufacturers/suppliers included in this website are FDA registered and has a certificate of current Good Manufacturing Practice (cGMP) issued by the FDA.
Languages: English
3. Brand Name
4. Manufacturer
5. Supplier
Drug search pattern is equivalent to the BNF of UK i.e. Drug Search by BNF Therapeutic Categories.
Pricing:
A good transparency has been maintained by the MoH, Philippines. The following type of Drug prices has been give on website
Drug Price Watch For Consumer
Drug Price Reference for Government
2015 Drug Price Reference Index Booklet
Drug Price Reference Index (DPRI) for all essential medicines to guide is published annually. Latest version in pdf format is valuable for the year 2016.
Also old edition of the same are available on the website like;
DPRI Booklet
a. Drug Price Reference 2016
b. Drug Price Reference 2015
c. Drug Price Reference 2013
d. Drug Price Reference 2012
What is the Drug Price Reference Index (DPRI)? The DPRI lists the ceiling prices of essential medicines for government bidding and procurement set by the DOH for all National and Local Government Health Facilities and Government Agencies. Winning bid prices of essential medicines within the DPRI ceiling reflect efficient and effective procurement in the government. Their transparencies and enforcement ensure consumer access to medicines and protection from excessive price mark-ups on medicines. The DPRI only reflects the acquisition costs including landed cost, packaging, drug content, quality assurance, manufacturing overheads and Food and Drug Administration (FDA) fees. The DPRI excludes other costs such as pharmacy services, preparation and storage fees, and other reasonable pharmacy mark-ups, which are now being evaluated by the DOH. The DPRI aims to improve the efficiency and good governance in the pricing and procurement of medicines in the public sector through establishing a transparent and publicly available reference price for affordable and quality medicines. It also aims to guide the Philippine Health Insurance Corporation (PHIC) in setting reimbursement caps for medicines both for inpatient and outpatient services. Who should use the DPRI? All government entities should be guided by the DPRI when procuring medicines. It shall be applied to all forms of procurement such as public bidding, direct contracting, shopping, negotiated procurement, emergency procurement and consignment to ensure that the government achieves the best value for money in sourcing essential medicines.
Disclaimer: All prices reflected are based on the lowest bidding procurement price conducted last 2015 of all DOH Hospitals. All manufacturers/suppliers included in this website are FDA registered and has a certificate of current Good Manufacturing Practice (cGMP) issued by the FDA.
Languages: English
No comments:
Post a Comment